ESTRO 2024 - Abstract Book

S867

Clinical - CNS

ESTRO 2024

Conclusion:

Stereotactic Radiotherapy was able to guarantee a good OS and LC in most patients for the ability to obtain a lesion response. Moreover, in our setting the use of Comprehensive Prognostic Index (CPI) showed to be an easily applicable tool with an optimal prognostic value to guide treatment decision.

Keywords: Clinical outcomes, Prognosis, Brain Metastases

References:

1. Stankiewicz M, Tomasik B, Blamek S. A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases. Sci Rep. 2021;11(1):20347. Published 2021 Oct 13. doi:10.1038/s41598-021-98847-3

1901

Digital Poster

Does clinical practice reflect data on the treatment of multiple brain metastases? a national survey

Silvia Chiesa 1 , Francesco Beghella Bartoli 1 , Giulia Marvaso 2 , Giulia Corrao 2 , Federico Mastroleo 2,3 , Fabiana Gregucci 4 , Elisabetta Lepre 1 , Ciro Franzese 5,6 , Barbara Alicja Jereczek-Fossa 2,7 , Marta Scorsetti 5,6 1 Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Department of Radiology, Radiation Oncology and Hematology, Rome, Italy. 2 IEO European Institute of Oncology IRCCS, Division of Radiation Oncology, Milan, Italy. 3 University of Piemonte Orientale (UPO), Department of Translational Medicine, Novara, Italy. 4 F. Miulli General Regional Hospital, Department of Radiation Oncology, Acquaviva delle fonti, Italy. 5 Humanitas University, Department of Biomedical Sciences, Milan, Italy. 6 Humanitas Research Hospital, Radiotherapy and Radiosurgery Department, Milan, Italy. 7 University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy

Purpose/Objective:

Recent studies reported results that are changing considerably the management of multiple brain metastasis, in particular in oligometastatic disease treated with new drugs. This survey was designed to analyze the real practice in the management of multiple brain metastases among the Italian Radiation Oncology community.

Material/Methods:

An online survey consisting of 31 questions was distributed to the members of the Associazione Italiana Radioterapia e Oncologia clinica (AIRO) and involving neurosurgeons. The questionnaire consisted of three